These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 14662691

  • 1. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.
    Nesto RW, Bell D, Bonow RO, Fonseca V, Grundy SM, Horton ES, Le Winter M, Porte D, Semenkovich CF, Smith S, Young LH, Kahn R, American Heart Association, American Diabetes Association.
    Circulation; 2003 Dec 09; 108(23):2941-8. PubMed ID: 14662691
    [No Abstract] [Full Text] [Related]

  • 2. [Heart failure with thiazolidinedione treatment: what do we know today?].
    Erdmann E.
    Dtsch Med Wochenschr; 2009 Jan 09; 134(4):154-8. PubMed ID: 19148858
    [Abstract] [Full Text] [Related]

  • 3. Thiazolidinediones and congestive heart failure: a judicious balance of risks and benefits.
    Patel RR.
    Cardiol Rev; 2009 Jan 09; 17(3):132-5. PubMed ID: 19384087
    [Abstract] [Full Text] [Related]

  • 4. Thiazolidinediones in type 2 diabetes: a cardiology perspective.
    Khanderia U, Pop-Busui R, Eagle KA.
    Ann Pharmacother; 2008 Oct 09; 42(10):1466-74. PubMed ID: 18698014
    [Abstract] [Full Text] [Related]

  • 5. Thiazolidinedione insulin sensitizers and the heart: a tale of two organs?
    Buckingham RE, Hanna A.
    Diabetes Obes Metab; 2008 Apr 09; 10(4):312-28. PubMed ID: 18333890
    [Abstract] [Full Text] [Related]

  • 6. Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus.
    Strowig SM, Raskin P.
    Diabetes Obes Metab; 2005 Nov 09; 7(6):633-41. PubMed ID: 16219007
    [Abstract] [Full Text] [Related]

  • 7. Pioglitazone/metformin (Actoplus met).
    Med Lett Drugs Ther; 2006 Jan 30; 48(1227):9-11. PubMed ID: 16444136
    [No Abstract] [Full Text] [Related]

  • 8. Thiazolidinediones and fluid retention.
    Kiryluk K, Isom R.
    Kidney Int; 2007 Sep 30; 72(6):762-8. PubMed ID: 17637710
    [No Abstract] [Full Text] [Related]

  • 9. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association.
    Nesto RW, Bell D, Bonow RO, Fonseca V, Grundy SM, Horton ES, Le Winter M, Porte D, Semenkovich CF, Smith S, Young LH, Kahn R.
    Diabetes Care; 2004 Jan 30; 27(1):256-63. PubMed ID: 14693998
    [No Abstract] [Full Text] [Related]

  • 10. [Glitazones and congestive heart failure: update on PROactive, ADOPT, DREAM and RECORD clinical trials].
    De Flines J, Scheen AJ.
    Rev Med Suisse; 2007 Aug 29; 3(122):1876, 1878-83. PubMed ID: 17896661
    [Abstract] [Full Text] [Related]

  • 11. Association between congestive heart failure and hospitalization in patients with type 2 diabetes mellitus receiving treatment with insulin or pioglitazone: a retrospective data analysis.
    Rajagopalan R, Rosenson RS, Fernandes AW, Khan M, Murray FT.
    Clin Ther; 2004 Sep 29; 26(9):1400-10. PubMed ID: 15531002
    [Abstract] [Full Text] [Related]

  • 12. Tolerability outcomes of a multicenter, observational, open-label, drug-surveillance study in patients with type 2 diabetes mellitus treated with pioglitazone for 2 years.
    Grossman LD, Parlan G, Bailey AL, Yee G, Yu M, Chan JY.
    Clin Ther; 2009 Jan 29; 31(1):74-88. PubMed ID: 19243708
    [Abstract] [Full Text] [Related]

  • 13. Risk of hospitalization for heart failure associated with thiazolidinedione therapy: a medicaid claims-based case-control study.
    Hartung DM, Touchette DR, Bultemeier NC, Haxby DG.
    Pharmacotherapy; 2005 Oct 29; 25(10):1329-36. PubMed ID: 16185176
    [Abstract] [Full Text] [Related]

  • 14. [Heart failure while taking glitazones--what do we know today?].
    Halbritter R.
    Dtsch Med Wochenschr; 2009 Jul 29; 134(28-29):1488; author reply 1488. PubMed ID: 19572255
    [No Abstract] [Full Text] [Related]

  • 15. Balancing risk and benefit with oral hypoglycemic drugs.
    Hamnvik OP, McMahon GT.
    Mt Sinai J Med; 2009 Jun 29; 76(3):234-43. PubMed ID: 19421967
    [Abstract] [Full Text] [Related]

  • 16. Type 2 diabetes mellitus and heart failure.
    Choy CK, Rodgers JE, Nappi JM, Haines ST.
    Pharmacotherapy; 2008 Feb 29; 28(2):170-92. PubMed ID: 18225964
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [2-year data of large clinical comparative studies. Type 2 diabetes: lasting metabolic control with pioglitazone].
    MMW Fortschr Med; 2004 Jul 22; 146(29-30):48-9. PubMed ID: 15540563
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.